Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -13.58% | -67.56% | 41.70% | -1,185.22% | -18.29% |
| Total Depreciation and Amortization | -30.66% | -27.05% | -24.54% | 16.52% | 23.81% |
| Total Amortization of Deferred Charges | 35.68% | 48.50% | 58.17% | 55.75% | 85.99% |
| Total Other Non-Cash Items | 40.35% | -32.51% | -31.02% | 1,391.61% | -19.93% |
| Change in Net Operating Assets | 22.00% | -1.12% | 21.34% | -129.92% | -20.23% |
| Cash from Operations | 78.46% | -33.96% | 4.33% | -12.35% | -32.20% |
| Capital Expenditure | -137.25% | -336.75% | 72.43% | -0.42% | 51.38% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -62.77% | 33.02% | 7.23% | 25.47% | 20.57% |
| Cash from Investing | -247.12% | 18.80% | 17.26% | 24.12% | 22.16% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -53.31% | 85.07% | -75.51% | 24.08% | -45.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -107.16% | -102.05% | -68.10% |
| Cash from Financing | -56.08% | 215.94% | -86.23% | -9.58% | -47.78% |
| Foreign Exchange rate Adjustments | 276.31% | -386.19% | 247.73% | -122.53% | -84.22% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -307.91% | -41.53% | 13.44% | -8.08% | 13.05% |